Clinicians from Columbia and Weill Cornell Medicine are at the forefront of pulmonary medicine and lung surgery combine leading-edge therapies with compassionate care for patients with all types and stages of lung disease. Our researchers are contributing to promising advances in acute lung injury, COPD, interstitial lung disease, and pulmonary hypertension.
Pulmonology & Lung Surgery
Featured Updates
NewYork-Presbyterian and Columbia was a key clinical trial site for daraxonrasib, which nearly doubled median survival compared with chemotherapy.
The Latest









